Biomaterials, Implants

The company is a medical device company that has developed a technological platform to carry out biomaterial surface modifications to medical implants that improves the utility of the implants. The use of medical implants can be met with several complications that include infection, blood clot formation, and adverse cell growth into the implant. The company’s production process imparts permanent antimicrobial surface technology to implants, without the use of drugs, and also decreases the risk of blood clots and cell growth invasion. Therefore this technology reduces the likelihood of medical device complications, without requiring the actual change of current medical practices using implants.

Click here for more information

The comments are closed.